News

Results of the Radiate study, which evaluated difficult-to-treat patients who failed to respond to prior anti-tumor necrosis factor (TNF)-alpha therapies, demonstrated that half of the patients treated with

Data presented demonstrate that a single administration of IPI-926 in a preclinical model of human pancreatic cancer results in rapid and sustained Hedgehog pathway inhibition in the stromal

The EU labeling provides for patients who require longer-term therapy to be treated for up to six months, with the usual course of therapy for typical patients being

The data presented are from studies measuring the effectiveness of an orally administered avian flu vaccine designed by Vaxart scientists using the company’s proprietary modular platform. The Vaxart

Anders Lonner, CEO of Meda, said: “This product has the potential to become the first once-a-day nasal antihistamine in the US. Beside better tolerance with the new formulation

According to the company, the initial personalized medicine services facilitate improved diagnostic, prognostic and therapeutic decision making for rheumatologists treating patients with rheumatoid arthritis (RA). Avise PG is

The Phase II study compared safety and efficacy of oral and intravenous forms of PTK 0796 to Zyvox in the treatment of patients with complicated skin and skin

The trial, conducted in accordance with FDA requirements, was a controlled, randomized, double-blind, partial cross-over study that compared Kamada’s intravenous alpha-1 antitrypsin (AAT) with a comparator product. Approximately

The Phase III study of almost 4,000 people 65 years of age and older compared the high-dose influenza vaccine with the standard inactivated influenza vaccine formulated for the